FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 217 filers reported holding FATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $415,647 | -83.4% | 41,194 | -63.1% | 0.25% | -82.7% |
| Q3 2022 | $2,500,000 | -15.1% | 111,545 | -6.1% | 1.43% | -19.6% |
| Q2 2022 | $2,943,000 | +17.4% | 118,778 | +83.7% | 1.78% | +11.5% |
| Q1 2022 | $2,507,000 | +85.7% | 64,665 | +180.2% | 1.59% | +48.3% |
| Q4 2021 | $1,350,000 | +32.9% | 23,081 | +34.7% | 1.08% | +60.0% |
| Q3 2021 | $1,016,000 | +5.2% | 17,134 | +54.0% | 0.67% | -1.9% |
| Q2 2021 | $966,000 | +75.0% | 11,128 | -19.4% | 0.68% | +70.4% |
| Q3 2020 | $552,000 | +29.0% | 13,807 | +10.8% | 0.40% | +13.6% |
| Q2 2020 | $428,000 | – | 12,463 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |